NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD
Taking everything into account, PFE scores 6 out of 10 in our fundamental rating. PFE was compared to 195 industry peers in the Pharmaceuticals industry. While PFE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PFE scores decently on growth, while it is valued quite cheap. This could make an interesting combination. Finally PFE also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROIC | 7.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Altman-Z | 2.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.64 | ||
Fwd PE | 7.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 12.43 | ||
EV/EBITDA | 7.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.44% |
24.54
-0.3 (-1.21%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.44% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.64 | ||
Fwd PE | 7.78 | ||
P/S | 2.23 | ||
P/FCF | 12.43 | ||
P/OCF | 9.97 | ||
P/B | 1.54 | ||
P/tB | N/A | ||
EV/EBITDA | 7.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROCE | 9.87% | ||
ROIC | 7.77% | ||
ROICexc | 8.64% | ||
ROICexgc | 41.11% | ||
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% | ||
FCFM | 17.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Debt/EBITDA | 2.45 | ||
Cap/Depr | 40.16% | ||
Cap/Sales | 4.43% | ||
Interest Coverage | 5.35 | ||
Cash Conversion | 58.69% | ||
Profit Quality | 142.33% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 | ||
Altman-Z | 2.15 |